Today, Paxman publishes the August issue of its newsletter aimed at shareholders, investors and other interested parties.

This month’s issue highlights that Paxman has received several important orders in its international markets, and the company’s distribution partners have installed scalp cooling systems in many countries including Brazil, the Czech Republic, France, India, Israel, Puerto Rico, Spain and Sweden.

The newsletter also includes an update on Paxman’s successful webinar in India where nurses from Massachusetts’s General Hospital and Mumbai Oncocare Cancer shared their experiences from using scalp cooling with over 490 livestreaming participants, and that Paxman has received several order and installed equipment in the UK and a number of US states.

Shareholders are also encouraged to submit questions on the company’s recently published Q2 2021 interim report for a CEO interview that will be published in the newsletter for next month.

To read the newsletter and subscribe for upcoming issues, follow this link:

http://bit.ly/paxaug21en

Paxman’s investor newsletter is published monthly as a part of the company’s effort to strengthen its market communication together with the IR communication agency Honeybadger. Every published issue of the newsletter is available on Paxman’s website for investors, www.paxman.se. The company encourages feedback and requests on topics for upcoming issues of the newsletter.

Contacts

Richard Paxman, CEO
Tel: +44 7968 020641
Email: richard@paxmanscalpcooling.com
www.paxman.se

About Us

The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 3,500 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK) and Houston, Texas (US).

The PAXMAN share is listed on Nasdaq First North Growth Market. FNCA Sweden AB is the company’s Certified Adviser and can be contacted via info@fnca.se and +46 (0)8 528 003 99.

Attachments

Paxman publishes newsletter on strong international order and installation activity during the summer

© Modular Finance, source Nordic Press Releases